國鼎 4132.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 4132)
4132 Value Score
3
24
15
Average Growth
- AI analysis rates 4132 with a medium value score of 3.
- It is mainly due to stable revenue growth, but with concerns regarding unstable operating cash flow.
- Over the past 3 months, 4132 has maintained a consecutive value rating of 3.0, slightly lower than the rating of 3.6 over the past 3 years, indicating decreasing growth opportunities for enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 4132 has a medium value rating.
4132 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2024/07/16 (Weekly Update)
4132 Financial Forecast
Unit : TWD
Update to 2025/5/13 (Quarterly Update)
4132 Earnings Table
No related data records
4132 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
4132 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 4132 from 2010/05 till Now
- -81.07%
- Cumulative Return
- -10.81%
- Annual Return
- 50.61%
- Volatility
- -0.21
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2010 to May, 2025. (Total Trades: 1)
| 4132 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | - | 46% | 53% |
| Avg Return | -81.2% | 21.1% | 45.4% |
| Avg Profit | - | 72.2% | 102.9% |
| Avg Loss | -81.2% | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/13 (Daily Update)